Subconjunctival 5-fluorouracil on the outcome of Ahmed valve in neovascular glaucoma

Evaluation of the effect of subconjunctival 5-fluorouracil on the outcome of Ahmed valve in neovascular glaucoma: Randomized Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210901052357N2

Enrollment

Registered

2022-05-23

Start date

2022-01-26

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neovascular glaucoma. Glaucoma

Interventions

Intervention 1: Intervention group:Patients with neovascular glaucoma undergoing shunt implant surgery with during surgery. This method will use Ahmad FP7 model valved shunt (New World Medical, LA), w

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with neovascular glaucoma Lack of eye pressure control with medication

Exclusion criteria

Exclusion criteria: Patients with other types of glaucoma

Design outcomes

Primary

Measure	Time frame
Intraocular pressure (IOP). Timepoint: Before surgery, first day, first week, third week, fifth week, third month, sixth month after surgery?. Method of measurement: Intraocular pressure is measured with a Goldmann Applanation Tonometer (GAT).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Najafzadeh

Iran University of Medical Sciences

Najafzadeh.Farhad@gmail.com+98 21 6651 6999

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026